The initial and subsequent inflammatory events during calcium oxalate lithiasis

Clinica Chimica Acta

Volumn 411, Issue 1-16, 2010, Pages 1018-1026

  Yuen, John W M ^a,c   Gohel, Mayur Danny I ^a   Poon, Ngork wah ^a   Shum, Daisy K Y ^b   Tam, Po chor ^b   Au, Doris W T ^c  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Calcium oxalate; Cell injury; Endocytosis; Hyaluronan; Proximal tubular cells; Renal stone

Indexed keywords

CALCIUM; CALCIUM OXALATE; HYALURONIC ACID; MESSENGER RNA; OXALIC ACID; WEDDELLITE;

ARTICLE; CELL CULTURE; CELL DAMAGE; CELL SURFACE; CONTROLLED STUDY; CRYSTALLIZATION; CULTURE MEDIUM; ELECTRON MICROSCOPY; ENDOCYTOSIS; HUMAN; HUMAN CELL; HYPERCALCIURIA; HYPEROXALURIA; INCUBATION TIME; INFLAMMATION; INTERNALIZATION; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UROLITHIASIS;

BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM OXALATE; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCURONOSYLTRANSFERASE; HUMANS; INFLAMMATION; KIDNEY TUBULES, PROXIMAL; LITHIASIS;

EID: 77953326723     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.03.015     Document Type: Article

References (47)

1. Grases F., Costa-Bauza A., Prieto R.M. Renal lithiasis and nutrition. Nutr J 2006, 5:23.
2. Lieske J.C., Spargo B.H., Toback F.G. Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 1992, 148:1517-1519.
3. Kok D.J., Khan S.R. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994, 46:847-854.
4. Rabinovich Y.I., Esayanur M., Daosukho S., et al. Adhesion force between calcium oxalate monohydrate crystal and kidney epithelial cells and possible relevance for kidney stone formation. J Colloid Interface Sci 2006, 300:131-140.
5. Bigelow M.W., Wiessner J.H., Kleinman J.G., Mandel N.S. Calcium oxalate crystal attachment to cultured kidney epithelial cell lines. J Urol 1998, 160:1528-1532.
6. Sheng X., Ward M.D., Wesson J.A. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation. J Am Soc Nephrol 2005, 16:1904-1908.
7. Khan S.R., Byer K.J., Thamilselvan S., et al. Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 1999, 10:S457-S463.
8. Bigelow M.W., Wiessner J.H., Kleinman J.G., Mandel N.S. The dependence on membrane fluidity of calcium oxalate crystal attachment to IMCD membranes. Calcif Tissue Int 1997, 60:375-379.
9. Lieske J.C., Huang E., Toback F.G. Regulation of renal epithelial cell affinity for calcium oxalate monohydrate crystals. Am J Physiol Renal Physiol 2000, 278:F130-F137.
10. Schepers M.S., Duim R.A., Asselman M., et al. Internalization of calcium oxalate crystals by renal tubular cells: a nephron segment-specific process?. Kidney Int 2003, 64:493-500.
11. Schepers M.S., van Ballegooijen E.S., Bangma C.H., Verkoelen C.F. Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells. Kidney Int 2005, 68:1543-1553.
12. Verkoelen C.F. Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan?. J Am Soc Nephrol 2006, 17:1673-1687.
13. Iida S., Suzuki K., Matsuoka K., et al. Analysis of glycosaminoglycans in human prostate by high-performance liquid chromatography. Br J Urol 1997, 79:763-769.
14. Gohel M.D., Shum D.K., Tam P.C. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis. Carbohydr Res 2007, 342:79-86.
15. Shum D.K., Gohel M.D., Tam P.C. Hyaluronans: crystallization-promoting activity and HPLC analysis of urinary excretion. J Am Soc Nephrol 1999, 10:S397-S403.
16. Shum D.K., Gohel M.D. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects. Clin Sci (Lond) 1993, 85:33-39.
17. Yoshida M., Sai S., Marumo K., et al. Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction. Arthritis Res Ther 2004, 6:R514-R520.
18. Jacobson A., Brinck J., Briskin M.J., Spicer A.P., Heldin P. Expression of human hyaluronan synthases in response to external stimuli. Biochem J 2000, 348:29-35.
19. Lieske J.C., Toback F.G., Deganello S. Direct nucleation of calcium oxalate dihydrate crystals onto the surface of living renal epithelial cells in culture. Kidney Int 1998, 54:796-803.
20. Shum D.K., Liong E. Calcium oxalate crystallizing properties of polyanions elaborated by cultured renal proximal tubular cells. Urol Res 1995, 23:103-110.
21. Verkoelen C.F., Romijn J.C., de Bruijn W.C., et al. Association of calcium oxalate monohydrate crystals with MDCK cells. Kidney Int 1995, 48:129-138.
22. Kavanagh J.P., Jones L., Rao P.N. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine. Clin Sci (Lond) 2000, 98:151-158.
23. Gohel M.D., Wong S.P. Chinese herbal medicines and their efficacy in treating renal stones. Urol Res 2006, 34:365-372.
24. Robertson W.G. Kidney models of calcium oxalate stone formation. Nephron Physiol 2004, 98:21-30.
25. Danpure C.J., Rumsby G. Molecular aetiology of primary hyperoxaluria and its implications for clinical management. Expert Rev Mol Med 2004, 6:1-16.
26. Robertson W.G. Is prevention of stone recurrence financially worthwhile?. Urol Res 2006, 34:157-161.
27. Rodgers A., lie-Hamdulay A., Jackson.G. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor. Nephrol Dial Transplant 2006, 21:361-369.
28. Neuhaus T.J., Belzer T., Blau N., et al. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 2000, 82:322-326.
29. Burns J.R., Finlayson B. Changes in calcium oxalate crystal, morphology as a function of concentration. Invest Urol 1980, 18:174-177.
30. Carvalho M., Vieira M.A. Changes in calcium oxalate crystal morphology as a function of supersaturation. Int Braz J Urol 2004, 30:205-208.
31. Costa-Bauza A., Perello J., Isern B., Sanchis P., Grases F. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth. BMC Urol 2006, 6:16.
32. Lieske J.C., Toback F.G., Deganello S. Face-selective adhesion of calcium oxalate dihydrate crystals to renal epithelial cells. Calcif Tissue Int 1996, 58:195-200.
33. Schepers M.S., van der Boom B.G., Romijn J.C., Schroder F.H., Verkoelen C.F. Urinary crystallization inhibitors do not prevent crystal binding. J Urol 2002, 167:1844-1847.
34. Verhulst A., Asselman M., Persy V.P., et al. Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding into a nonadherent epithelium. J Am Soc Nephrol 2003, 14:107-115.
35. Verkoelen C.F., van der Boom B.G., Houtsmuller A.B., Schroder F.H., Romijn J.C. Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 1998, 274:F958-F965.
36. Verkoelen C.F., van der Boom B.G., Kok D.J., et al. Cell type-specific acquired protection from crystal adherence by renal tubule cells in culture. Kidney Int 1999, 55:1426-1433.
37. Bigelow M.W., Wiessner J.H., Kleinman J.G., Mandel N.S. Calcium oxalate-crystal membrane interactions: dependence on membrane lipid composition. J Urol 1996, 155:1094-1098.
38. Wiessner J.H., Hasegawa A.T., Hung L.Y., Mandel G.S., Mandel N.S. Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 2001, 59:637-644.
39. Goswami A., Singhal P.C., Wagner J.D., et al. Matrix modulates uptake of calcium oxalate crystals and cell growth of renal epithelial cells. J Urol 1995, 153:206-211.
40. Lieske J.C., Swift H., Martin T., Patterson B., Toback F.G. Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci U S A 1994, 91:6987-6991.
41. Lieske J.C., Toback F.G. Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. Am J Physiol 1993, 264:F800-F807.
42. Lewington A.J., Padanilam B.J., Martin D.R., Hammerman M.R. Expression of CD44 in kidney after acute ischemic injury in rats. Am J Physiol Regul Integr Comp Physiol 2000, 278:R247-R254.
43. Ito T., Williams J.D., Al-Assaf S., Phillips G.O., Phillips A.O. Hyaluronan and proximal tubular cell migration. Kidney Int 2004, 65:823-833.
44. Asselman M., Verhulst A., van Ballegooijen E.S., et al. Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 2005, 68:71-83.
45. Goentzel B.J., Weigel P.H., Steinberg R.A. Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem J 2006, 396:347-354.
46. Knepper M.A., Saidel G.M., Hascall V.C., Dwyer T. Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer. Am J Physiol Renal Physiol 2003, 284:F433-F446.
47. Asselman M., Verhulst A., De Broe M.E., Verkoelen C.F. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 2003, 14:3155-3166.